Background: Retinoic acid (RA) is a key regulator of embryonic development and linked to several birth defects including cleft lip and palate (CLP). The aim was to investigate the effects of RA on proliferation and gene expression of human palatal keratinocytes (KCs) in vitro. Methods: KCs from children with and without CLP were cultured with 2 and 5 μM RA. Proliferation was measured by quantification of DNA after 2, 4, 6, and 8 days. In addition, we analysed the effects of RA on messenger RNA expression of genes for proliferation, differentiation, apoptosis, and RA receptors. Results: RA similarly inhibited proliferation of palatal KC from cleft and non-cleft subjects. The proliferation of KCs from cleft subjects was reduced to 59.8 ± 13.4% (2 μM) and 41.5 ± 14.0% (5 μM, Day 6), while that of cells from age-matched non-cleft subjects was reduced to 66.9 ± 12.1% (2 μM) and 33.9 ± 10.1% (5 μM). RA treatment reduced the expression of several of the investigated genes; the proliferating cell nuclear antigen (PCNA) was reduced in CLP KCs only. Keratins 10 and 16 were downregulated in keratinocytes from both cleft and non-cleft subjects. P63, a master regulator for epithelial differentiation, was only downregulated in KCs from cleft subjects, as was the RXRa receptor. Two P63 target genes (GJB6 and DLX5) were strongly downregulated by RA in all cell lines. None of the apoptosis genes was affected. Conclusion: Overall, RA similarly inhibits proliferation of palatal KCs from cleft and non-cleft subjects and reduces the expression of specific genes.
Introduction
Cleft lip and palate (CLP) is the most common craniofacial birth defect in humans and is caused by impaired fusion of the embryonic facial prominences. In the aetiology of CLP, both genetic and environmental factors are involved (Dixon et al., 2011) . One of the most extensively studied environmental factors is maternal nutrition. The maternal diet during the first trimester is crucial for the development of various organs as well as the orofacial complex (Vujkovic et al., 2007) . An excess or deficiency of micronutrients can lead to congenital malformations and is also associated with CLP (Cetin et al., 2010) . Vitamins are of particular interest because they cannot be synthesized by the body. They play key roles in growth and development and can be considered as vital ingredients of embryonic nutrition (Mark et al., 2009) . The genetic makeup of individuals might render higher sensitivity to vitamin excess or deficiency to cause CLP (Boyles et al., 2008; Boyles et al., 2009; Manolescu et al., 2010) .
The fat-soluble vitamin A, or more precisely its derivate retinoic acid (RA), is an important regulator of embryogenesis. RA regulates proliferation, differentiation, and apoptosis during the morphogenesis of embryonic structures (Finnell et al., 2004) . RA regulates gene expression through the activation of the retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These receptors regulate their target genes by binding to specific DNA elements in the regulatory regions, which are called retinoic acid response elements (RAREs) (Blomhoff et al., 1990; Blomhoff and Blomhoff, 2006; Campo-Paysaa et al., 2008) . RA receptor knockout studies have illustrated the importance of RA signalling in palatogenesis. These knockouts exhibit orofacial clefting in addition to the agenesis or malformation of other craniofacial structures (Mark et al., 2009) . The developmental stage at the time of exposure determines the sensitivity to CLP induction. In humans, RA exposure seems most critical between developmental Weeks 4 and 12 (Abbott et al., 1989) . In this particular period, excessive vitamin A may disturb all three stages of palatogenesis; shelf outgrowth, shelf elevation, and shelf fusion (Ackermans et al., 2011; Choi et al., 2011) .
Keratinocytes (KCs) are known to respond to RA differently in vivo and in vitro. In vivo, RA induces the proliferation of basal KCs and stimulates differentiation in higher epidermal layers, resulting in epidermal thickening (Fisher and Voorhees, 1996; Feng et al., 1997) . In vitro, however, RA inhibits the proliferation and differentiation of both epidermal and oral KCs (Kastner et al., 1995; Chung et al., 1997; Hietanen et al., 1998; Pol et al., 2003; Schwartz, 1999) . RA can also induce apoptosis in several cancer cell lines and is therefore used in cancer therapies (Niizuma et al., 2006; Noy, 2010; Masetti et al., 2012) . In epidermal KCs, RA does not induce apoptosis directly but enhances apoptosis induced by ultraviolet B radiation (UVB) or chemicals (Mrass et al., 2004) .
Since palatal KCs play an important role in the proper fusion of the palatal shelves, we hypothesized that the proliferation of palatal KCs from CLP patients is more sensitive to RA than that of non-cleft subjects. Therefore, in this study, we compared the effects of RA on proliferation and gene expression of palatal KCs from CLP patients and agematched non-cleft subjects in vitro.
Materials and methods

Keratinocytes
Palatal KCs (passage 2) were derived from biopsy specimens from the palatal mucosa of four children with CLP (age 19 ± 1 months) and four children without CLP (age 26 ± 1 months). The collection of the samples and KC culture were described previously (Liu et al., 2008) . In brief, the donor children with a cleft were all treated in the Cleft Palate Craniofacial Unit of the Radboud University Nijmegen Medical Centre. They all had a non-syndromic cleft palate with or without cleft lip and alveolus. Control individuals were age-matched children without congenital birth defects who were scheduled for tonsillectomy at the Ear-Nose-Throat department of the same hospital.
The Central Ethical Committee of the Netherlands approved the study protocol, which included written informed consent from the parents. During the primary surgical closure of the cleft palate, a 3 mm biopsy of the palatal mucosa was taken in the middle of the hard palate, about 1 cm from the medial edge of the cleft. In the non-cleft children, a biopsy was taken during tonsillectomy, at about 1 cm from the palatal midline. The KCs were cultured from the biopsy samples on a feeder layer of 3T3 cells and stored in liquid nitrogen (Liu et al., 2008) .
Cell culture
For the assessment of proliferation, KCs (passage 3) were cultured in fourfold in 96-well flat bottom culture plates (8 × 10 3 cells per well) in 200 μl keratinocyte growth medium (KGM) and incubated at 37°C. KGM was composed of keratinocyte basal medium supplemented with penicillin (100 U/ml), streptomycin (100 U/ml), bovine pituitary extract (0.4%), ethanolamine (0.1 mM), phosphoethanolamine (0.1 mM), hydrocortisone (0.5 μg/ ml), insulin (5 μg/ml), and epidermal growth factor (10 μg/ ml). After 24 hours of attachment, the cells were cultured for 2, 4, 6, or 8 additional days in fresh medium containing 0, 2, or 5 μM all-trans-RA(Sigma-Aldrich, Saint Louis, Missouri, USA) and 0.1% dimethyl sulfoxide (DMSO). Medium was changed at Days 2, 4, and 6. RA-containing stock solutions and media were protected from light at any time. After culture, the cells were washed with Dulbecco's phosphate-buffered saline (DPBS) and digested with papain (0.9 mg/ml) in 0.2 M NaCl, 0.1 M NaAc, 0.01 M L-cysteine HCL, and 0.05 M ethylene diaminetetraacetic acid with pH 6.0 at 60°C to liberate the DNA for analysis. Then the samples were centrifuged and frozen at −20°C. For the analysis of gene expression, palatal KCs from four non-cleft children and four CLP patients were seeded in twofold in 6-well plates (2.5 × 10 5 cells per well) in 2 ml KGM and incubated at 37°C. When the cells reached 40-60% confluency, they were cultured for an additional 24 hours in medium containing 2 μM RA and 0.1% DMSO and in medium with DMSO only (control). Then, the cells were washed with 1 ml DPBS, and 1 ml Trizol (TRIzol® Reagent, Ambion-Invitrogen, Carlsbad, California, USA) was added to extract messenger RNA (mRNA) for the expression analysis. The samples were harvested and stored at −80°C.
Cell proliferation assay and DNA quantification
Cell proliferation was measured by quantification of doublestranded DNA (dsDNA) using the Quant-iT TM PicoGreen® dsDNA Assay Kit (Life Technologies Corporation, Carlsbad, California, USA). Sample fluorescence was measured at excitation and emission wavelengths of 485 and 530 nm (sensitivity 75) using a Bio-Tek FL600 microplate fluorescence reader (Bio-Tek Instruments Inc., Winooski, Vermont, USA). DNA concentrations were calculated from a standard curve of DNA ranging from 0 to 2000 ng/ml.
Reverse transcription followed by Quantitative polymerase chain reaction
After homogenization with Trizol, chloroform was added, and the sample was centrifuged. RNA was extracted from the upper aqueous phase with the RNeasy MiniKit (Qiagen, Hilden, Germany). cDNA was generated with 1 μg of RNA using the iScript TM Reverse Transcriptase system (BioRad, Hercules, California, USA), according to the manufacturer's protocol. Reverse transcription-quantitative polymerase chain reaction (PCR) was performed in duplicate in a total reaction volume of 25 μl containing 12.5 μl SYBR Green Supermix (Bio-Rad), 5 μl of cDNA, 4.5 μl of RNAse-free water, 3 μl of 2.5 μM forward primer, and 3 μl of 2.5 μM reverse primer. The primers for PCNA, K10, K14, K16, CystatinM/E, Involucrin, Caspase 3, p53, RARβ, RXRα, IRF6, CDH3, GJB6, DLX5, DLX6, GJA1 , and hARP were obtained from Biolegio (Nijmegen, the Netherlands). Primer sequences are provided in Table 1 . All primers are exon spanning wherever possible.
The cDNA amount was amplified in the C1000 Thermal Cycler (Bio-Rad), and fluorescence was analysed using the CFX96 Real-Time System (Bio-Rad). The PCR conditions were one cycle at 95°C for 3 minutes, followed by 39 cycles of 95°C for 15 seconds and 60°C for 30 seconds, and finally a temperature increase from 65°C to 95°C at 0.5°C intervals. The amount of gene expression was normalized to the expression of mRNA of the human acidic ribosomal protein P0 (hARP) as a reference gene, and presented as 2 −ΔCt . We used hARP as a housekeeping gene because it is more stable in KCs than actin or GAPDH (de Jongh et al., 2005) . The expression of the ∆Np63α isoform was calculated from the average expression of the ∆N-and the α-isoform.
Statistical analysis
The DNA data were calculated as a percentage of the controls without RA treatment for each cell line at each time point because of the large individual differences. The relative amounts of DNA at each time point were compared by a two-way analysis of variation and a Holm-Sidak post hoc test to analyze the effects of donor type and RA concentration. A value of P < 0.05 was considered significant.
The expression data (2 −ΔCt ) were calculated as a percentage of the control without RA (100%) for each cell line. The effect of RA was then evaluated by a one-sample t-test for the difference with 100%. The effect of donor type was evaluated by a regular t-test. A value of P < 0.05 was considered significant.
Results
The effects of RA on keratinocyte proliferation
KCs from children with and without CLP (henceforth referred to as cleft and non-cleft KCs) were cultured with 0, 2, and 5 μM RA. Proliferation was measured by quantification of dsDNA after 2, 4, 6, and 8 days. The cell lines showed a large inter-individual variation in growth rate and response to RA ( Figure 1A ). Some cell lines showed growth acceleration after a few days of incubation (NC3 and CLP2). The growth curves seem to flatten as cell density increases. In addition, at 2 µM RA, the KCs seem to lose their characteristic organization into dense colonies, while, at 5 µM, the cells develop an irregular morphology ( Figure 1B ). No differences were observed between cleft and non-cleft KCs. RA inhibited the proliferation of palatal KCs in a dose-dependent manner. In order to exclude the individual differences, the data from Figure 1 were calculated as a percentage of the controls without RA treatment for each cell line. Significant inhibition by 2 μM RA was only observed at Days 4, 6, and 8 (P < 0.05), while the effect of 5 μM RA was significant at all days (P < 0.05). Only the results for Proliferation  PCNA  TCAGGTACCTCAGTGCAAAAG  TGCAAGTGGAGAACTTGGAA  Ki-67  TGACTTCCTTCCATTCTGAAGAC  TGGGTCTGTTATTGATGAGCC  Differentiation  K10  TGGTTCAATGAAAAGAGCAAGGA  GGGATTGTTTCAAGGCCAGTT  K14  GGCCTGCTGAGATCAAAGACTAC  CACTGTGGCTGTGAGAATCTTGTT  K16  GATCATTGCGGCCACCAT  TGCTCATACTTGGTCCTGAAGTCA  CysM/E  TCCGAGACACGCACATCATC  CCATCTCCATCGTCAGGAAGTAC  Involucrin  ACTTATTTCGGGTCCGCTAGGT  GAGACATGTAGAGGGACAGAGTCAAG  p63ΔN  CAATGCCCAGACTCAATTTAGTGA  TGCTGGTCCATGCTGTTCAG  P63α  TCCATGGATGATCTGGCAAGT  GCCCTTCCAGATCGCATGT  p63 target genes  IRF6  TTCTGGTGGACAGATTGAGC  AGGGCCATGATATGGAAGAG  CDH3  CAGGACACCTTCCGAGGGA  GGATGGAGTAAGCAACCACCC  GJB6  CAAGAGGACTTCGTCTGCAAC  GGGAAAAAGTGGTCATAGCACA  DLX5  TTCCAAGCTCCGTTCCAGAC  GAATCGGTAGCTGAAGACTCG  DLX6  GGGGACGACACAGATCAACAA  GTCTGCTGAAAGCGATGGTTT  GJA1  CTGGAACTTATTGGGTGGCAT  CCAGCATTCGGAAGATGAAGAG  Apoptosis  Casp3  GTCGATGCAGCAAACCTCAG  CAACACCACTGTCTGTCTCAA  P53 GCATTCTGGGACAGCCAAGT Day 6 are shown in detail (Figure 2) . In cleft KCs, proliferation was reduced to 59.8 ± 13.4% (2 μM, P < 0.05) and 41.5 ± 14.0% (5 μM, P < 0.05) at Day 6, respectively. The proliferation of age-matched non-cleft KCs was reduced to 66.9 ± 12.1% (2 μM, P < 0.05) and 33.9 ± 10.1% (5 μM, P < 0.05). The differences between cleft and non-cleft KCs were not statistically significant at any time point (P > 0.05).
The effects of RA on gene expression
The expression of all genes was determined after culture with or without 2 µM RA for 24 hours. The mRNA levels of the proliferation marker genes PCNA and Ki-67 were analysed in palatal KC obtained from cleft and non-cleft subjects ( Figure 3A ). The expression of PCNA was downregulated only in cleft KCs after RA treatment (P < 0.05). The expression of Ki-67 was not affected by RA in both cleft and non-cleft KCs. No significant differences between the cleft and non-cleft KCs were found. The expression of several differentiation genes was also analysed ( Figure 3B ). The expression of K10 and K16 was downregulated in the RA-treated cells of both cleft and non-cleft KCs (P < 0.05). Interestingly, only in CLP patients p63 was downregulated in RA-treated cells (P < 0.05), while the difference between the cleft and noncleft KCs was also significant (P = 0.02). The expression of K14, Involucrin (INV), and CystatinM/E (CysM/E) was not significantly affected by RA. The effect of RA on several genes that are involved in apoptosis is shown in Figure 3C . No significant effects of RA on Caspase 3 (Casp3), p53, and c-Jun expression were found, but p53 and c-Jun tended to be downregulated.
RA might regulate the expression levels of retinoid receptors, and therefore the mRNA levels of RARβ and RXRα were analysed ( Figure 3D ). RA downregulated the expression of RXRα only in cleft KCs (P < 0.05). No significant differences between cleft and non-cleft KCs were found.
Since P63 was downregulated by RA only in cleft KCs, we also analyzed the expression of the P63 target genes IRF6, CDH3, GJB6, and DLX5 (Figure 4 ). The expression of GJA1 and DLX6 was too low for reliable determination (Ct > 30). The expression of both GJB6 and DLX5 was significantly reduced by RA (P < 0.05) in cleft KCs as well as non-cleft KCs. Figure 1 . Because of the large individual differences, the effects of 2 and 5 μM RA are shown relative to the control without RA treatment (100%). There was a significant effect for both RA concentrations (*P < 0.05) but no significant difference between non-cleft and CLP KCs.
Figure 1 (A) Keratinocyte proliferation. KCs from four non-cleft children (NC1-NC4) and four CLP patients (CLP1-CLP4) were cultured for up to 8 days with 0, 2, and 5 μM RA. Then, the DNA content was determined. Note the large inter-individual variation in growth rate and response to RA. Also note the flattening of the curves if a DNA concentration of around 10 μg/ml is reached. CLP1 was only measured until 6 days, as a high number of dead cells was detected at Day 8 and therefore excluded. (B) Keratinocyte morphology. The figure shows representative pictures of the cell cultures at Day 6. At 2 µM RA, the KCs seem to lose their characteristic organization into dense colonies, while, at 5 µM, the cells develop an irregular morphology. No differences were observed between KCs from cleft and non-cleft subjects.
Discussion
High periconceptional vitamin A intake might disturb crucial cellular processes during palatogenesis such as cell proliferation, differentiation, and apoptosis (Meng et al., 2009; Ackermans et al., 2011) . Epithelia of the palatal shelves play a key role in the fusion of the shelves during palate development. Therefore, in this study, we have investigated the putative pathogenic effects of RA on palatal KCs from CLP patients and non-cleft subjects by assessing the effects of RA on the proliferation of palatal KCs. In addition, we analysed the effects of RA on marker genes for proliferation, differentiation, and apoptosis. Our hypothesis was that the cleft KCs are more sensitive to inhibition of proliferation by RA than non-cleft KCs, which may be due to their genetic background. There is evidence that cells from children with and without cleft palate are genetically (Baroni et al., 2010) and phenotypically (Baroni et al., 2006) different. Individuals with specific polymorphisms of enzymes or other proteins involved in vitamin A metabolism might have an increased risk of CLP (Boyles et al., 2009; Manolescu et al., 2010) .
In this study, we found a significant inhibition of keratinocyte proliferation in response to RA, which was also previously shown by others (Hietanen et al., 1998; Schroeder and Zouboulis, 2007; Popadic et al., 2008) . Another study, using skin KCs from adult donors, did not observe any negative effect of RA on keratinocyte growth (Pol et al., 2003) . This might be explained by the different cell type and the shorter culture period in the latter study. We also found large inter-individual variations in growth rate and response to RA between all cell lines. This finding was also reported by others (Popadic et al., 2008) . Individual differences in response to RA may be due to variations in expression of Figure 3 The effects of RA on gene expression. KCs from four children with CLP and four non-cleft children were cultured in medium containing 2 μM RA and in control medium. After a culture period of 24 hours, mRNA levels for several sets of genes were determined: proliferation genes (A), differentiation genes (B), apoptosis genes (C), and RA receptor genes (D). Expression levels are shown as a percentage of the controls without RA treatment (100%, dashed lines). (*) represents a significant effect on gene expression and (#) indicates a significant difference between cells from CLP patients and non-cleft subjects.
Figure 4
The effects of RA on expression of P63 target genes. KCs from four children with CLP and four non-cleft children were cultured in medium containing 2 μM RA and in control medium. After a culture period of 24 hours, mRNA levels for several P63 target genes were determined. Expression levels are shown as a percentage of the controls without RA treatment (100%, dashed lines). (*) represents a significant effect on gene expression and (#) indicates a significant difference between cells from CLP patients and non-cleft subjects. retinoid receptors or polymorphisms in genes involved in RA metabolism.
We further studied the effects of RA on proliferation by investigating the expression of specific marker genes. Despite the clear inhibition of KC proliferation in culture, there was no clear effect of RA on the expression of proliferation genes. Although the expression of PCNA was significantly reduced, that of Ki-67 was not affected. This might be related to the different function of these two markers in the cell cycle (Tachibana, 2005) or to the short culture period.
Since correct epithelial differentiation is crucial for palatal fusion (Meng et al., 2009) , we also studied the effects of RA on several genes related to differentiation. The majority of these markers seemed to show a tendency to decrease in RA-treated cultures. We observed a significant inhibition of K10 and K16 expression in both cleft and non-cleft KCs. K10 is normally expressed in the suprabasal layers of skin epithelium and palatal mucoperiosteum. The expression of K10 is known to be downregulated in proliferating cells (Santos et al., 2002) , which is consistent with our results. We also found that K16 is downregulated in RA-treated cells. K16 is present in the suprabasal layers of keratinized oral mucosa, while in epidermis it is expressed only in hyperproliferative skin diseases such as psoriasis (Chu and Weiss, 2002; Dale et al., 1990; Paramio et al., 1999) . The expression of cystatin M/E, an inhibitor of asparaginyl endopeptidase required for envelope maturation (Zeeuwen et al., 2002) , was also determined but it showed no change after RA treatment. We also analysed the effects of RA on the expression of p63, which is a transcription factor that regulates KC proliferation and differentiation (Koster, 2010) . Interestingly, p63 was the only gene showing a significant difference in mRNA levels between cleft and noncleft KCs. P63 is a key regulator of orofacial development and p63 knockout mice have severe developmental impairments (Mills et al., 1999; Yang et al., 1999) . Mutations in the human p63 gene cause different syndromes in which CLP is one of the major hallmarks (Rinne et al., 2007; Koster, 2010) . The p63 gene is expressed as multiple isoforms by encoding two different N-termini (TA and ΔN) and multiple C-termini (α, β, γ, δ, and ε). ΔNp63α, the most predominantly expressed p63 isoform in late embryonic and postnatal epithelial cells, regulates KC differentiation (Truong and Khavari, 2007) . Therefore, we specifically investigated the expression of the ΔNp63α isoform using both ΔN-and α-isoform-specific primers (see Material and methods). Inhibition of p63 expression might lead to impaired differentiation of the palatal epithelium and thus prevent palatal fusion. In fact, several RAR binding motifs lie near the p63 gene, which might explain the inhibition of expression (H. Zhou, unpublished data). However, the expression of IRF6, which interacts with P63 during palatogenesis in mouse embryos, was not affected (Thomason et al., 2010) . Mutations in this gene cause van de Woude syndrome, of which CLP is one of the phenotypes. The expression of two other P63 target genes, GJB6 and DLX5, was reduced by RA. However, this reduction was observed in both cleft and non-cleft KCs. GJB6 is involved in epithelial cell contacts and, if mutated, can cause ectodermal dysplasia (Shalom-Feuerstein et al., 2011) . Dlx genes, such as DLx5, encode for the distalless-related homeodomain transcription factors that play key roles in the development and morphogenesis of the head and limb skeleton (Lo Iacono et al., 2008) . The consequences of downregulation of these P63 targets by RA for keratinocyte physiology and palatogenesis have to be further studied.
Apoptosis is a crucial process in embryonic development including palatogenesis (Cuervo and Covarrubias, 2004) . We did not observe a clear effect of RA on apoptosis marker genes, but the expression of p53 and c-Jun showed a cautious tendency to decrease in both cleft and non-cleft KCs. In future experiments, it might be interesting to study the effects of RA on cellular apoptosis during longer culture periods. RA has been reported to induce apoptosis in various cell types such as human neuroblastoma cells and rat tracheobronchial epithelial cells (Chateau and Boehm, 1996) . In addition, RA is shown to enhance the expression of the important apoptosis regulators Caspases 3, 6, 7, 9 and p53, in human epidermal KCs treated with UVB or doxorubicin (Mrass et al., 2004) .
Further, we observed that RXRα is downregulated in RA-treated cleft KCs, while RARβ tended to be upregulated in both. RARs and RXRs belong to the nuclear receptor superfamily and mediate the transcriptional activities of RA by binding to short DNA sequences (RAREs and RXREs) (Kastner et al., 1995; Pfahl, 1996) . Both RARs and RXRs occur in three different subtypes; α, β, and γ, which allows various heterodimer combinations. All three RARs are expressed in fetal mouse palate during palatal shelf development with increased levels of RARβ (Naitoh et al., 1998) . RA might regulate the expression levels of the receptor mRNA. In our study, RARβ mRNA levels showed a weak propensity to increase, which is consistent with another study showing that RA upregulates RARβ in fetal mouse secondary palate both in vitro and in vivo (Naitoh et al., 1998) . RXRα is the most essential RXR isotype during embryogenesis, as it can perform most of the developmental functions of RXRs alone (Krezel et al., 1996) . The downregulation of RXRα in CLP patients might reduce RA binding and subsequently result in reduced RA function.
Conclusion
This study shows that RA inhibits the proliferation of KCs from both cleft and non-cleft subjects but with large inter-individual differences. Moreover, the expression of some differentiation markers was reduced in the RA-treated palatal KCs from both cleft and non-cleft subjects. More detailed studies on the effects of RA on the proliferation and differentiation of palatal KCs will provide further information on the possible pathogenic effects of RA in the development of clefts.
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